Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxidatively modified low density lipoprotein
- PMID:1914111
- DOI: 10.1161/01.cir.84.4.1725
Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxidatively modified low density lipoprotein
Abstract
Background: In vitro and in vivo experiments have demonstrated the role of oxidatively modified low density lipoprotein (oxLDL) in eliciting leukocyte/endothelium interaction during early atherogenesis.
Methods and results: In the present study we investigated the effect of dietary fish oil on oxLDL-induced leukocyte/endothelium interaction using intravital fluorescence microscopy in the dorsal skinfold chamber model in awake Syrian golden hamsters. Hamsters were fed for 4 weeks prior to the experiments with either standard laboratory chow or a diet supplemented with 5% of a fish oil concentrate (18% eicosapentaenoate, 12% docosahexaenoate). The efficacy of the fish oil diet was demonstrated by the incorporation of fish oil-derived omega-3 fatty acids into plasma, leukocyte, and erythrocyte lipids. In control hamsters (n = 7) and fish oil-fed hamsters (n = 7), leukocyte/endothelium interaction was assessed in the time course after intravenous injection of human LDL (4 mg/kg), oxidized by 7.5 microM Cu2+ (6 hours, 37 degrees C). In control hamsters, injection of oxLDL elicited the rolling and sticking of leukocytes to the endothelium of arterioles and postcapillary venules with a maximum 15 minutes after injection (arterioles: from 3 +/- 1 to 91 +/- 25 cells/mm2 at 15 minutes; venules: from 13 +/- 6 to 150 +/- 46 cells/mm2 at 15 minutes; mean +/- SD). This phenomenon was significantly reduced in fish oil-fed hamsters, where 15 minutes after injection of oxLDL leukocyte sticking reached a maximum of only 15 +/- 7 and 20 +/- 5 cells/mm2 in arterioles and postcapillary venules, respectively (p less than 0.01 versus control animals).
Conclusions: The results of the present study suggest that inhibition of leukocyte/endothelium interaction may be one of the mechanisms by which dietary fish oil exerts its protective effects on experimental and clinical atherogenesis.
Similar articles
- Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters.Lehr HA, Hübner C, Finckh B, Angermüller S, Nolte D, Beisiegel U, Kohlschütter A, Messmer K.Lehr HA, et al.J Clin Invest. 1991 Jul;88(1):9-14. doi: 10.1172/JCI115309.J Clin Invest. 1991.PMID:2056134Free PMC article.
- Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex.Lehr HA, Kröber M, Hübner C, Vajkoczy P, Menger MD, Nolte D, Kohlschütter A, Messmer K.Lehr HA, et al.Lab Invest. 1993 Apr;68(4):388-95.Lab Invest. 1993.PMID:8097545
- P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo.Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hübner C, Berndt MC, Steinberg D, Messmer K, Arfors KE.Lehr HA, et al.Lab Invest. 1994 Sep;71(3):380-6.Lab Invest. 1994.PMID:7523762
- Inhibition of leukocyte-endothelial interactions by oxidized omega-3 fatty acids: a novel mechanism for the anti-inflammatory effects of omega-3 fatty acids in fish oil.Sethi S.Sethi S.Redox Rep. 2002;7(6):369-78. doi: 10.1179/135100002125001144.Redox Rep. 2002.PMID:12625944Review.
- N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.Connor WE, DeFrancesco CA, Connor SL.Connor WE, et al.Ann N Y Acad Sci. 1993 Jun 14;683:16-34. doi: 10.1111/j.1749-6632.1993.tb35689.x.Ann N Y Acad Sci. 1993.PMID:8352438Review.
Cited by
- n-3 fatty acids and lipoproteins: comparison of results from human and animal studies.Harris WS.Harris WS.Lipids. 1996 Mar;31(3):243-52. doi: 10.1007/BF02529870.Lipids. 1996.PMID:8900453Review.
- Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus.McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR.McVeigh GE, et al.Diabetologia. 1993 Jan;36(1):33-8. doi: 10.1007/BF00399090.Diabetologia. 1993.PMID:8436250Clinical Trial.
- Dietary supplementation with omega-3-PUFA-rich fish oil reduces signs of food allergy in ovalbumin-sensitized mice.de Matos OG, Amaral SS, Pereira da Silva PE, Perez DA, Alvarenga DM, Ferreira AV, Alvarez-Leite J, Menezes GB, Cara DC.de Matos OG, et al.Clin Dev Immunol. 2012;2012:236564. doi: 10.1155/2012/236564. Epub 2011 Nov 17.Clin Dev Immunol. 2012.PMID:22162714Free PMC article.
- Effects of dietary fish oil and soy phosphatidylcholine on neutrophil fatty acid composition, superoxide release, and adhesion.Guarini P, Bellavite P, Biasi D, Carletto A, Galvani S, Caramaschi P, Bambara LM, Corrocher R.Guarini P, et al.Inflammation. 1998 Aug;22(4):381-91. doi: 10.1023/a:1022368832035.Inflammation. 1998.PMID:9675609Clinical Trial.
- Omega-3 fatty acids. Current status in cardiovascular medicine.Schmidt EB, Dyerberg J.Schmidt EB, et al.Drugs. 1994 Mar;47(3):405-24. doi: 10.2165/00003495-199447030-00003.Drugs. 1994.PMID:7514972Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources